Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Biomed Eng ; 4(8): 814-826, 2020 08.
Article in English | MEDLINE | ID: mdl-32231313

ABSTRACT

The long-term function of transplanted therapeutic cells typically requires systemic immune suppression. Here, we show that a retrievable implant comprising a silicone reservoir and a porous polymeric membrane protects human cells encapsulated in it after implant transplantation in the intraperitoneal space of immunocompetent mice. Membranes with pores 1 µm in diameter allowed host macrophages to migrate into the device without the loss of transplanted cells, whereas membranes with pore sizes <0.8 µm prevented their infiltration by immune cells. A synthetic polymer coating prevented fibrosis and was necessary for the long-term function of the device. For >130 days, the device supported human cells engineered to secrete erythropoietin in immunocompetent mice, as well as transgenic human cells carrying an inducible gene circuit for the on-demand secretion of erythropoietin. Pancreatic islets from rats encapsulated in the device and implanted in diabetic mice restored normoglycaemia in the mice for over 75 days. The biocompatible device provides a retrievable solution for the transplantation of engineered cells in the absence of immunosuppression.


Subject(s)
Cell Transplantation/methods , Graft Survival , Prostheses and Implants , Animals , Capsules , Cell Transplantation/instrumentation , Coated Materials, Biocompatible , Diabetes Mellitus, Experimental/therapy , Equipment Design , Erythropoietin/genetics , Erythropoietin/metabolism , Foreign-Body Reaction/prevention & control , HEK293 Cells , Humans , Islets of Langerhans , Islets of Langerhans Transplantation/instrumentation , Islets of Langerhans Transplantation/methods , Mice , Permeability , Rats , Transplantation, Heterologous
2.
Adv Mater ; 32(16): e1904502, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32134138

ABSTRACT

Encapsulated beta cell transplantation offers a potential cure for a subset of diabetic patients. Once transplanted, beta cell grafts can help to restore glycemic control; however, locating and retrieving cells in the event of graft failure may pose a surgical challenge. Here, a dual-function nanoparticle-loaded hydrogel microcapsule is developed that enables graft retrieval under an applied magnetic field. Additionally, this system facilitates graft localization via magnetic resonance imaging (MRI), and graft isolation from the immune system. Iron oxide nanoparticles encapsulated within alginate hydrogel capsules containing viable islets are transplanted and the in vitro and in vivo retrieval of capsules containing nanoparticles functionalized with various ligands are compared. Capsules containing islets co-encapsulated with COOH-coated nanoparticles restore normal glycemia in immunocompetent diabetic mice for at least 6 weeks, can be visualized using MRI, and are retrievable in a magnetic field. Application of a magnetic field for 90 s via a magnetically assisted retrieval device facilitates rapid retrieval of up to 94% (±3.1%) of the transplant volume 24 h after surgical implantation. This strategy aids monitoring of cell-capsule locations in vivo, facilitates graft removal at the end of the transplant lifetime, and may be applicable to many encapsulated cell transplant systems.


Subject(s)
Diabetes Mellitus, Experimental/diagnostic imaging , Diabetes Mellitus, Experimental/pathology , Insulin-Secreting Cells/transplantation , Magnetic Phenomena , Magnetic Resonance Imaging , Animals , Capsules , Ferric Compounds/chemistry , Mice , Nanoparticles/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...